Sign in
4

Changes in Ownership

EXELIXIS, INC. Filed Acc 0000939767-22-000122

EVP, Scientific Strategy & CSO sold 20,000 shares at $15.88 ($317,600)

  • EVP, Scientific Strategy & CSO acquired 20,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Lamb Peter · EVP, Scientific Strategy & CSO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-12-15 Exercise or conversion : show line 1 in the form +20,000 $4.20 $84,000 430,958 D
2022-12-15 Sale : show line 2 in the form −20,000 $15.88 $317,600 410,958 D
Open-market sales · 20,000 sh · avg $15.88 · $317,600

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-12-15 Exercise or conversion : show line 3 in the form Option (right to buy) −20,000 20,000 D
Loading xslF345X03/wf-form4_167123936903484.xml…